000 | 01301 a2200349 4500 | ||
---|---|---|---|
005 | 20250513114109.0 | ||
264 | 0 | _c19970429 | |
008 | 199704s 0 0 eng d | ||
022 | _a0002-9440 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaurer, M | |
245 | 0 | 0 |
_aHair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. _h[electronic resource] |
260 |
_bThe American journal of pathology _cApr 1997 |
||
300 |
_a1433-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 |
_aAlopecia _xchemically induced |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCyclophosphamide _xtoxicity |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xanalogs & derivatives |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHair Follicle _xdrug effects |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
700 | 1 | _aHandjiski, B | |
700 | 1 | _aPaus, R | |
773 | 0 |
_tThe American journal of pathology _gvol. 150 _gno. 4 _gp. 1433-41 |
|
999 |
_c9077966 _d9077966 |